Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

CompletedOBSERVATIONAL
Enrollment

326

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)Thrombocytopenic Purpura
Interventions
OTHER

Retrospective Chart Review

Retrospective chart review for up to 36 months of enrollment date.

OTHER

Patient-reported Outcome Questionnaires

Quality of lige questionnaires as well as treatment satisfaction questionnaires are required monthly. Includes QOL, ITP-PAQ (immune thrombocytopenic purpura - patient assessment questionnaire), EQ-5D, and TSQM (Treatment Satisfaction Questionnaire for Medication).

OTHER

Physician Survey

Physician characteristics to be collected include demographics, years of practice, medical specialty or primary treating physician, and the referral process.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY